(Q28270615)

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

A potent and selective endogenous agonist for the mu-opiate receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Pharmacology of dynorphin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Analgesic effects of dynorphin-A and morphine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Analgesic efficacy of the kappa-receptor agonist, enadoline, in dental surgery pain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

U-50,488, a selective kappa opioid agonist: Comparison to other reputed kappa agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

kappa-Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Dynorphin: a possible modulatory peptide on morphine or beta-endorphin analgesia in mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Effect of kappa-opioid receptor agonists on morphine analgesia in morphine-naive and morphine-tolerant rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

U-50,488 blocks the development of morphine tolerance and dependence at a very low dose in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Intrathecally administered dynorphin-(1-17) modulates morphine-induced antinociception differently in morphine-naive and morphine-tolerant rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Involvement of spinal kappa opiod receptors in the antagonistic effect of dynorphins on morphine antinociception

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Spinal dynorphin A (1-17): possible mediator of antianalgesic action

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Antagonism of mu-opioid receptor-mediated inhibitions of nociceptive neurones by U50488H and dynorphin A1-13 in the rat dorsal horn

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Neurotransmitters in Nociceptive Modulatory Circuits

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

A review of the role of anti-opioid peptides in morphine tolerance and dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Suppression by dynorphin A-(1-13) of the expression of opiate withdrawal and tolerance in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

The mechanism of action for the block of NMDA receptor channels by the opioid peptide dynorphin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

A selective kappa-opioid agonist, U-50,488H, blocks the development of tolerance to morphine analgesia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Dynorphin A-(1-13) attenuates withdrawal in morphine-dependent rats: effect of route of administration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Dynorphin-(1-13): effects in nontolerant and morphine-dependent rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Opioid peptides induce reduction of enkephalin receptors in cultured neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Molecular characterization of opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

The effect of single and repeated morphine administration on the prodynorphin system activity in the nucleus accumbens and striatum of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Brain dynorphin and enkephalin systems in Fischer and Lewis rats: effects of morphine tolerance and withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1-13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Neurobiology of opiate abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Discriminative stimulus and subjective effects of opioids with mu and kappa activity: data from laboratory animals and human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Kappa opioid inhibition of morphine and cocaine self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Blockade of morphine reward through the activation of kappa-opioid receptors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Effects of the kappa-opioid receptor agonist U-50,488 on morphine-induced place preference conditioning in the developing rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Aversive properties of the kappa opioid agonist U50,488 in the week-old rat pup.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Drugs of abuse: anatomy, pharmacology and function of reward pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Memory retrieval enhancement by kappa opioid agonist and mu, delta antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Effects of the kappa-opioid dynorphin A(1-13) on learning and memory in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Long-term potentiation and learning

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Endogenous opioid regulation of hippocampal function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Psychotomimesis mediated by kappa opiate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Mu and delta receptors belong to a family of receptors that are coupled to potassium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Opioid actions on single nucleus raphe magnus neurons from rat and guinea-pig in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Opioids activate both an inward rectifier and a novel voltage-gated potassium conductance in the hippocampal formation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

kappa-Opioid receptors also increase potassium conductance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Activation of μ opioid receptors inhibits transient high- and low-threshold Ca 2+ currents, but spares a sustained current

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Dynorphin A selectively reduces a large transient (N-type) calcium current of mouse dorsal root ganglion neurons in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Kappa-opioid receptor activation modulates Ca2+ currents and secretion in isolated neuroendocrine nerve terminals.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021

Opioids excite dopamine neurons by hyperpolarization of local interneurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2898%2901169-9

7 January 2021